Adipotide/ FTPP 2mgs/vial (10vial)

Adipotide, also known as FTPP (Fat Targeted Proapoptotic Peptide), is an experimental peptide compound that has garnered interest for its potential in the treatment of obesity and related metabolic disorders.

The description for Adipotide 2mg typically refers to a vial or container containing 2 milligrams of the Adipotide peptide. Adipotide works by selectively targeting and binding to blood vessels that supply fat tissue, leading to the destruction of fat cells through a process known as apoptosis, or programmed cell death. By inducing the apoptosis of fat cells, Adipotide aims to reduce body fat mass and potentially contribute to weight loss.

It’s important to note that Adipotide is still in the experimental stages of research and development, and its safety and efficacy in humans have not been conclusively established. Clinical trials and studies are ongoing to assess its potential benefits and risks.

As with any experimental or investigational medication, Adipotide should only be used under the supervision of qualified healthcare professionals and within the context of approved clinical trials or research protocols. Potential side effects and long-term effects of Adipotide therapy are still being investigated.